X
19
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXCARBAZEPINE, with a corresponding application number 21285.
Regulatory Information RX
With a dosage strength 300MG/5ML
Dosage Form Route SUSPENSION; ORAL
Reference Listed Drug Yes
Approved since 2001-05-25
Therapeutic Equivalence (TE) Code AB